Hepatocellular recurrence after orthotopic liver transplantation: Is combination of ?-fetoprotein and glypican-3 a reliable marker?

AUTHORS

Mohammad Hashemi 1 , Saeid Ghavami 2 , *

1 Department of Clinical Biochemistry, School of Medicine, Zahedan Medical University, IR Iran

2 Manitoba Institute of Child Health, Department of Physiology, University of Manitoba, [email protected], Canada

How to Cite: Hashemi M, Ghavami S. Hepatocellular recurrence after orthotopic liver transplantation: Is combination of ?-fetoprotein and glypican-3 a reliable marker?, Hepat Mon. Online ahead of Print ; 11(3):155-156.

ARTICLE INFORMATION

Hepatitis Monthly: 11 (3); 155-156
Article Type: Editorial
Received: March 9, 2011
Accepted: March 15, 2011

Crossmark

CHEKING

READ FULL TEXT
Abstract

Please cite this paper as:
Hashemi M, Ghavami S. Hepatocellular recurrence after orthotopic liver trasplantation: Is α-fetoprotein and glypican-3 a reliable marker?Hepat Mon. 2011;11(3):155-156.

Keywords

Liver transplantation Alpha fetoproteins Glypican-3

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: